PDCI’s President and Principal Consultant, Neil Palmer is scheduled to Chair Day 3 – Stream 2 of the 4th Annual PHARMACCESS Leaders Forum. In addition to chairing, Mr. Palmer will be giving a presentation entitled “HTA, funding & reimbursement of cell & gene therapies: A global perspective.”

Topics covered include:

• Health technology assessment challenges in assessing clinical and cost effectiveness of cell / gene therapies.
• Who pays? Healthcare system determinants of funding / reimbursement paradigm.
• Affordability: Pricing and budget impact challenges.

This meeting will provide an ideal opportunity for “payers” and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies an invaluable insight into the decision making processes and approaches of these vital stakeholders. Attendees will be able to understand and develop best practice approaches to such vital and common challenges, with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications.